TCNNF - Company ID 0001754195
The table below shows Trulieve Cannabis Corp.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $286.75M | $288.19M | $302.09M | $297.76M | $284.28M | $303.44M |
| Cost of revenue | $116.67M | $118.33M | $119.16M | $114.54M | $111.01M | $121.79M |
| Gross profit | $170.08M | $169.86M | $182.93M | $183.22M | $173.28M | $181.65M |
| R&D | - | - | - | - | - | - |
Trulieve Cannabis Corp. reported annual revenue of $1.18B for fiscal year 2025. That is down 0.4% from $1.19B in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $252.82M (FY 2019) to $1.18B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $104.89M | $99.02M | $101.12M | $118.77M | $148.62M | $102.58M |
| Operating income | $35.73M | $42.24M | $52.63M | $33.33M | $618.00K | $49.75M |
| Income tax | $21.86M | $53.04M | $54.72M | $52.46M | $47.38M | $47.20M |
| Net income | - | - | - | - | -$61.60M | -$11.98M |
| EPS (diluted) | - | - | - | -$0.16 | -$0.32 | -$0.04 |